EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The SARM1 TIR domain produces glycocyclic ADPR molecules as minor products

Jeremy Garb iD, Gil Amitai, Allen Lu iD, Gal Ofir, Alexander Brandis, Tevie Mehlman, Philip J Kranzusch, Rotem Sorek

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0302251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jeremy Garb und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. Hauptthemen laut MEDLINE: Wallerian Degeneration, NAD. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Israel Science Foundation, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sterile alpha and TIR motif-containing 1 (SARM1) is a protein involved in programmed death of injured axons. Following axon injury or a drug-induced insult, the TIR domain of SARM1 degrades the essential molecule nicotinamide adenine dinucleotide (NAD + ), leading to a form of axonal death called Wallerian degeneration. Degradation of NAD + by SARM1 is essential for the Wallerian degeneration process, but accumulating evidence suggest that other activities of SARM1, beyond the mere degradation of NAD + , may be necessary for programmed axonal death. In this study we show that the TIR domains of both human and fruit fly SARM1 produce 1′′–2′ and 1′′–3′ glycocyclic ADP-ribose (gcADPR) molecules as minor products. As previously reported, we observed that SARM1 TIR domains mostly convert NAD + to ADPR (for human SARM1) or cADPR (in the case of SARM1 from Drosophila melanogaster ). However, we now show that human and Drosophila SARM1 additionally convert ~0.1–0.5% of NAD + into gcADPR molecules. We find that SARM1 TIR domains produce gcADPR molecules both when purified in vitro and when expressed in bacterial cells. Given that gcADPR is a second messenger involved in programmed cell death in bacteria and likely in plants, we propose that gcADPR may play a role in SARM1-induced programmed axonal death in animals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wallerian DegenerationNADAnimalsHumansDrosophila melanogasterAxonsBacteriaAdenosine Diphosphate RiboseArmadillo Domain ProteinsCytoskeletal Proteins

Substanzen

NADAdenosine Diphosphate RiboseArmadillo Domain ProteinsSARM1 protein, humanCytoskeletal Proteins

Autor:innen und Institutionen

  • Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
  • Department of Microbiology, Harvard Medical School, Boston, MA, United States of America.
  • Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
  • Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, Boston, MA, United States of America.

ORCID-Profile: Jeremy Garb, Allen Lu

Förderung

  • European Research Council
  • Israel Science Foundation
  • Deutsche Forschungsgemeinschaft
  • G. Harold and Leila Y. Mathers Foundation

Zitieren

APA

Garb, J., Amitai, G., Lu, A., Ofir, G., Brandis, A., Mehlman, T., Kranzusch, P. J., & Sorek, R. (2024). The SARM1 TIR domain produces glycocyclic ADPR molecules as minor products. PLOS ONE. https://doi.org/10.1371/journal.pone.0302251

Vancouver

Garb J, Amitai G, Lu A, Ofir G, Brandis A, Mehlman T, et al. The SARM1 TIR domain produces glycocyclic ADPR molecules as minor products. PLOS ONE. 2024. doi:10.1371/journal.pone.0302251

BibTeX
@article{Garb2024,
  author = {Garb, Jeremy and Amitai, Gil and Lu, Allen and Ofir, Gal and Brandis, Alexander and Mehlman, Tevie and Kranzusch, Philip J and Sorek, Rotem},
  title = {The SARM1 TIR domain produces glycocyclic ADPR molecules as minor products},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0302251}
}
Kostenlos starten →